Skip to main content
. 2009 Mar 28;15(12):1499–1505. doi: 10.3748/wjg.15.1499

Table 1.

Association between PRL-3 expression and clinicopathological features

Factors Patients PRL-3 expression
P value
Positive (n = 127) Negative (n = 266)
Gender
Male 194 85 109 NS
Female 99 42 57
Age (yr)
< 60 149 66 83 NS
≥ 60 144 61 83
Tumor size (cm)
≥ 5 118 63 55 0.004
< 5 175 64 111
Depth of invasion
T1 22 5 17 0.008a
T2 46 15 31 0.009b
T3 175 77 98 0.042c
T4 50 30 20
Lymph node metastasis
N0 82 30 52 < 0.0001d
N1 120 42 78
N2 51 33 18
N3 40 22 18
Distant metastasis
Present 42 21 21 NS
Absent 251 106 145
Vascular/lymphatic invasion
Present 162 89 73 < 0.0001
Absent 131 38 93
Differentiation
Poor 194 91 103 NS
Well/Moderate 99 36 63
Surgical curability
Curative 200 79 121 NS
Not curative 93 48 45
Recurrencee
Absent 177 63 114 0.002
Present 23 16 7
TNM stages
I 42 13 29 0.007f
II 52 17 35 0.008g
III 99 43 56
IV 100 54 46

NS: Not significant;

a

T1-T2 vs T3-T4;

b

T1-T3 vs T4;

c

T1 vs T2-4;

d

N0-N1 vs N2-N3;

e

200 cases received curative surgery;

f

I-II vs III-IV;

g

I-III vs IV.

HHS Vulnerability Disclosure